StockNews.com upgraded shares of Enzo Biochem (NYSE:ENZ – Free Report) to a sell rating in a research report released on Friday morning. Enzo Biochem Stock Performance ENZ stock opened at $1.41 on Friday. The company has a 50 day moving average price of $1.43 and a 200 day moving average price of $1.80. The stock […]
FARMINGDALE, NY, Oct. 30, 2023 Enzo Biochem, Inc. , a leading life sciences company, announced today that Steven J. Pully has been appointed to the Company’s Board of Directors effective.
Enzo Biochem (ENZ) Appoints Steven J Pully to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The In Vitro Toxicology Testing industry is poised for a transformative evolution in the near future, driven by advancements in technology,.
/PRNewswire/ The non-alcoholic steatohepatitis market size is expected to grow by USD 11.22 billion from 2022 to 2027. In addition, the momentum of the.